Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis Patients

Size: px
Start display at page:

Download "Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis Patients"

Transcription

1 Med. J. Cairo Univ., Vol. 83, No. 2, December: , Diagnosis of Spontaneous Bacterial Peritonitis by Identification of 16s rrna Genes in Liver Cirrhosis Patients MONA A. AMIN, M.D.; AHMED E. EL-BADRY, M.D.; DINA SABRY, M.D.* and AHMED YOUSSEF, M.Sc. The Departments of Internal Medicine and Medical Biochemistry*, Faculty of Medicine, Cairo University 209 Introduction SPONTANEOUS bacterial peritonitis (SBP) is a common and severe complication in patients with cirrhosis and ascites, occurring in 10-25% of patients, with in-hospital mortality rate ranging from 20 to 40% [1,2]. Early bacterial detection and characterization would allow targeted intervention to prevent the development of SBP, or where peritonitis is already present, treatment with the most appropriate therapy. Culture-based analysis of ascitic fluid has shown that a wide range of bacterial species can be isolated. Despite this, even where the most modern practice is applied, ascites fluid culture is negative in approximately 20% of patients with clinical manifestations suggestive of SBP, including elevated ascites polymorphonuclear leukocyte (PMN) counts. Where there is evidence of infection, delaying treatment until the ascitic fluid culture grows bacteria may result in the death of the patient from overwhelming infection [3]. Therefore, empirical antibiotic treatment for SBP is initiated when objective evidence of a local inflammatory reaction is present without prior knowledge of the causative organisms or their antibiotic susceptibility [4]. In contrast to culture-based methodologies, the rapid and accurate identification of bacteria in clinical samples using molecular, culture independent approaches has led to the rapid proliferation of the use of such strategies. Their particular strength is in their ability to detect bacterial species, regardless of whether these species can be grown readily in vitro [5,6]. In the study presented here, we investigated the potential of culture-independent strategy to

2 210 Diagnosis of Spontaneous Bacterial Peritonitis by Identification characterize the bacterial content of ascites fluid. Our strategy is the confirmation of species identities through 16S ribosomal gene clone sequence analysis. Patients and Methods Between October 2013 and June 2014, we prospectively enrolled 100 consecutive patients with liver cirrhosis and ascites diagnosed as SBP or clinically suspected at Internal Medicine Department Kasr El-Aini Hospital. Cirrhosis was diagnosed using physical examination, standard laboratory and radiological findings. SBP diagnosis was established by clinical manifestations and ascitic fluid neutrophil count is 250/mm 3 with no evidence of an intraabdominal source of infection. After approval of our faculty ethical committee informed consent was obtained from each participant or a responsible family member after fully explaining the possible complications of the diagnostic procedures. All patients were subjected to thorough history and clinical evaluation with special emphasis on conscious level, temperature, abdominal pain, tenderness & previous history of SBP. Laboratory investigations were done in form of: Complete blood count (CBC), serum bilirubin, AST, ALT, prothrombin time and concentration, serum albumin, Creatinine and BUN. Paracentesis performed under aseptic conditions. Ascitic fluid samples examined for total leucocytic count (TLC) and polymorphnuclear leucocytes (PMN), culture and sensitivity of ascitic fluid. 16s rrna genes by polymerase chain reaction quantitative method in ascitic fluid. Inclusion criteria were patients with liver cirrhosis and ascites with following criteria: 1- Patients with SBP diagnosed by clinical manifestations and PMN cell count in ascitic fluid is more than 250 cells/mm Patients with culture-negative nonneutrocytic ascites (CNNNA) (ascitic fluid neutrophil count <250/mm 3 and negative culture) with manifestation suggestive of SBP. 3- Sudden deterioration of general condition in cirrhotic patients. The exclusion criteria included the following: 1- Patients with an alternative cause for increased ascitic fluid neutrophil count (i.e. bloody ascites, pancreatitis or tuberculosis). 2- Upper gastrointestinal bleeding or intake of antibiotics in the preceding 2 weeks before study. 3- Hepatocellular carcinoma, or portal vein thrombosis and transjugular intrahepatic portosystemic shunt (TIPS). Statistical analysis: Pre-coded data was entered on the computer using "Microsoft Office Excel Software" program (2010) for windows. Data was then transferred to the Statistical Package of Social Science Software program, version 21 (SPSS) to be statistically analyzed. Receiver operating characteristics (ROC) curve analysis was conducted to explore the discriminant ability of Gene expression 16s RRNA in predicting positive ascetic cultures. p-values less than 0.05 were considered statistically significant, and less than 0.01 were considered highly significant [7]. Results From the 100 patients we studied, 77 patients were confirmed SBP (clinical symptoms, signs and ascitic fluid neutrophil count is 250/mm 3 ) and 23 patients were clinically suspected SBP (clinical symptoms, signs or Sudden deterioration of general condition with ascitic fluid neutrophil count <250/mm 3 ) (Fig. 1). Ascitic fluid culture was positive only in 4 patients and 96 patient had negative cultures. Gene expression 16s RRNA in ascitic fluid was positive in all patients with a mean level (3.3±3.8). All the studied cases had positive 16s rrna gene expression (100%) and its levels were not correlated with any of the laboratory parameters (p-value >0.05), its levels were only correlated with results of ascitic fluid culture where 16s rrna level was significantly higher in culture positive cases when compared to those with culture negative cases (p-value = 0.002). (Table 1), (Fig. 2). In predicting positive cultures area under the curve for 16s RRNA gene expression [0.909, 95% confidence interval (CI) ]. At a 16s rrna cut-off value of 5.1 the test achieved a a PPV of 22.2%, sensitivity 100%, specificity 85.4%, NPV 100% and total accuracy of 84% (Table 2), (Fig. 3). According to the results of ascitic fluid culture and sensitivity the patients were divided into 2 groups culture positive (no=4) and culture negative (no=96). There was no statistically significant difference in the different laboratory parameters between those with culture positive and those with culture negative results (p-value >0.05). The only difference between both groups was the level of 16s rrna which was higher in culture positive

3 Mona A. Amin, et al. 211 when compared to those with culture negative (pvalue = 0.002) (Table 3) (Fig. 2). According to the results of ascitic fluid polymorphnuclear leucocytes (PMN) the patients were divided into 2 groups proved SBP (PMN 250/ mm 3 ) and clinically suspected SBP (PMN <250/ mm 3 ). There was no statistically significant difference in different laboratory parameters between those proved SBP and those suspected SBP (pvalue >0.05), the only difference between both groups was in ascitic total leucocytic count which was higher in those with proved SBP compared to those suspected SBP (p-value <0.001) (Tables 4,5). Suspected SBP 23% SBP Suspected SBP Confirmed SBP 77% Fig. (1): Percentage of patients diagnosed as SBP and those clinically suspected. 1.0 Gene expression 16s RRNA 9.1 Table (1): Correlation between the relative gene expression 16s RRNA and the other laboratory parameters. Tested variable Gene expression 16s RRNA Relative gene expression 16s RRNA r p-value Hb (g/dl) WBC (/µl) Plt (10 9 /L) PC INR AST (IU/L) ALT (IU/L) Albumin (g/dl) Urea (mg/dl) Creatinine (mg/dl) Total Bil (mg/dl) Direct Bil (mg/dl) TLC (ascitic) PMN (ascitic) Table (2): Area under the curve & cut off point for 16s RRNA gene expression. AUC 95% CI p-value Tested variable Gene expression 16s RRNA Cut off point Specificity Sensitivity PPV NPV Accuracy % 85.4% 22.2% 100.0% 84.0% 0.0 +VE Culture VE Fig. (2): Relation between the relative gene expression 16s RRNA and culture results. Sensitivity ROC Curve Specificity Fig. (3): ROC curve analysis to explore the discriminant ability of Gene expression 16s RRNA in predicting +VE cultures. Table (3): Comparison between laboratory parameters according to culture results. +VE (n=4) Culture VE (n=96) p value Hb (g/dl) 9.10± ± WBC (/µl) 6.00± ± Plt (10 9 /L) ± ± PC 51.50± ± INR 2.05± ± AST (IU/L) 55.75± ± ALT (IU/L) 63.75± ± Albumin (g/dl) 2.13± ± Urea (mg/dl) 39.75± ± Creatinine (mg/dl) 1.15± ± Total Bil (mg/dl) 1.53± ± Direct Bil (mg/dl) 1.10± ± TLC (ascitic) ± ± PMN (ascitis) ± ±

4 212 Diagnosis of Spontaneous Bacterial Peritonitis by Identification Table (4): Comparison of laboratory parameters according to ascitic fluid PMN leucocytic count. PMN Clinically suspected SBP <250 (n=23) Proved SBP 250 ( n=77) p value Hb (g/dl) 8.57± ± WBC (/µl) 7.20± ± Plt (10 9/L) ± ± PC 51.00± ± INR 1.97± ± AST (IU/L) 37.52± ± ALT (IU/L) 39.70± ± Albumin (g/dl) 2.17± ± Urea (mg/dl) 35.83± ± creatinine (mg/dl) 1.03± ± Total Bil (mg/dl) 1.30± ± Direct Bil (mg/dl) 0.80± ± TLC (ascitic) ± ± <0.001 Gene expression 3.38± ± s RRNA Table (5): Comparison of ascitic fluid culture results according to ascitic fluid PMN leucocytic count. PMN C&S Clinically suspected Proved SBP p (ascitic) SBP <250 (n=23) 250 ( n=77) value N % N % +VE VE NS Discussion Bacterial identification by sequencing of the 16S ribosomal RNA (rrna) gene is a universal bacterial identification method. Bacterial taxonomists have used this technology for a number of years as a measure of DNA similarity between isolates. More recently 16S rrna gene amplification and sequencing has been used to detect and identify fastidious bacterial pathogens [8]. In our study which was done on 100 patients presented with symptoms such as low grade fever, rapidly accumulating ascites, unexplained deterioration of general condition and some of them had abdominal pain. They were admitted to the hospital suspected of having SBP and diagnostic paracentesis was done for all patients. PMN was found <250 cells/mm 3 in 23 patients and 250 c ells/mm 3 in 77 patients. Ascitic fluid cultures were found negative in 96 patient and positive only in 4 patients accordingly 23 patients were diagnosed as culturenegative non-neutrocytic ascites (ascitic fluid neutrophil count <250/mm 3 and negative culture) (CNNNA). 16s rrna gene expression in ascitic fluid was positive in all 100 patients suspected to have SBP even in CNNNA, culture negative or patients had PMN <250 cells/mm 3. There was no correlation between 16s rrna levels and the different laboratory parameters of our cases, it is only correlated with the results of ascitic fluid culture where its levels was higher in culture positive compared to those with culture negative. According to the results of ascitic fluid culture and sensitivity the patients were divided into 2 groups culture positive (no=4) and culture negative (no=96) with no significant difference between both groups in all laboratory parameters except 16s rrna levels. According to the results of ascitic fluid polymorphnuclear leucocytes (PMN) the patients were divided into 2 groups proved SBP (PMN 250/mm 3 ) and clinically suspected SBP (PMN <250/mm 3 ) with no significant difference in the laboratory parameters between both groups except for ascitic fluid TLC. Upon clinical suspicion of SBP diagnostic paracentesis was done and start Cefotaxime IV 2gm every 8 hours for 5 days. Our patients actually had clinical improvement 2-3 days after starting the antibiotic. We initiate empiric therapy as soon as possible to maximize the patient's chance of survival. These recommendations are consistent with a 2009 guideline issued by the American Association for the Study of Liver Diseases (AASLD). Accordingly 23% of patients CNNNA and 96% of patients with negative ascitic fluid cultures had already pathogenic bacteria in ascitic fluid causing SBP but undiagnosed. So ascitic fluid 16s RRNA gene expression can detect ascitic fluid pathogenic bacteria and SBP in CNNNA and culture negative SBP patients which represent large percentage of patients we meet in our daily practice. Previous studies reported the culture-positive rate of SBP ascites to be high, namely ranging between 72% and 90% of cases [9,10]. On the other hand, the rate of culture-positive cases was obviously low in our study despite the fact that ascitic fluid cultures were performed by the standard (culture-bottle) method. However, this low culturepositive rate of SBP ascites has been also observed in several reports, with a proportion between 39% and 59% and they suggested that the low rate probably depended on an earlier diagnosis of the infection [11,12].

5 Mona A. Amin, et al. 213 Our results are in accordance with the conclusion of Zapater et al. [13] and Bruns et al. [14] where both studies agree that identification of ascitic Bacterial DNA is an appropriate alternative to bacterial ascites culture for pathogen identification in patients at risk for SBP. Mohamed et al. [15] concluded that identification of bacterial DNA in serum and ascitic fluid has its significant clinical and diagnostic relevance in suspicion of SBP and its prompt therapy especially in CNNNA. It might be an alternative diagnostic tool to ascitic bacterial culture in early diagnosis and prompt treatment with subsequent improvement of survival which needs further investigations. Here, we propose that it is more likely lowlevel colonization exist in the absence of a neutrophil response. The current use of the ascitic PMN to base clinical decisions with help from occasional positive cultures may therefore be a vast oversimplification with the data from this initial study suggesting that this needs to be revised subsequently. Conclusion: Identification of bacterial 16s RRNA in ascitic fluid has its significant clinical and diagnostic relevance in suspicion of SBP and its prompt therapy especially in CNNNA. It might be an alternative diagnostic tool to ascitic fluid bacterial culture and PMN in early diagnosis and prompt treatment with subsequent improvement of survival. Recommendations: From our study we recommend Reassessment of ascitic 16s rrna in patients with ascites due to other causes (not liver cirrhosis), Trying to add ascitic fluid 16s rrna gene expression to the diagnostic criteria of SBP in patient with liver cirrhosis. References 1- THULUVATH P.J., MORSS S. and THOMPSON R.: Spontaneous bacterial peritonitis in-hospital mortality, predictors of survival, and health care costs from 1988 to Am. J. Gastroenterol., 96: , PARK Y.H., LEE H.C., SONG H.G., JUNG S., RYU S.H., SHIN J.W., CHUNG Y.H., LEE Y.S. and SUH D.J.: Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J. Gastroenterol. Hepatol., 18: , RUNYON B.A.: AASLD Practice Guidelines Committee Management of adult patients with ascites due to cirrhosis: an update. Hepatology, 49: , RIMOLA A., GARCÍA-TSAO G., NAVASA M., PID- DOCK L.J., PLANAS R., BERNARD B. and INADOMI J.M.: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. International Ascites Club. J. Hepatol., 32: , WHELEN A.C. and PERSING D.H.: The role of nucleic acid amplification and detection in the clinical microbiology laboratory. Annu. Rev. Microbiol., 50: , ESPY M.J., UHL J.R., SLOAN L.M., BUCKWALTER S.P., JONES M.F., VETTER E.A., YAO J.D., WENGEN- ACK N.L., ROSENBLATT J.E., COCKERILL F.R. 3 rd and SMITH T.F.: Real-time PCR in clinical microbiology: Applications for routine laboratory testing. Clin. Microbiol. Rev., 19: , DAWSON B. and TRAPP R.G.: Basic and clinical biostatistics; Mcgraw-Hill Inc. Third edition., RELMAN D.A., SCHMIDT T.M., MacDERMOTT R.P. and FALKOW S.: Identification of the uncultured bacillus of Whipple s disease. N. Engl. J. Med., 327: , MOORE K.P. and AITHAL G.P.: Guidelines on the management of ascites in cirrhosis.gut, 55: vi1-vi12, RUNYON B.A., HOEFS J.C. and MORGAN T.R.: Ascitic fluid analysis in malignancy-related ascites. Hepatology, 8: 1104, GINES P., ANGELI P., LENZ K., et al.: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol., 53: , FERNANDEZ J., NAVASA M., GOMEZ J., COLMEN- ERO J., VILA J., ARROYO V., et al.: Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology, 35: , ZAPATER P., FRANCÉS R., GONZÁLEZ-NAVAJAS J.M., de la HOZ M.A., MOREU R., PASCUAL S., et al.: Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis. Hepatology, 48 (6): , BRUNS T., SACHSE S., STRAUBE E., ASSEFA S., HERRMANN A., HAGEL S., LEHMANN M. and STALLMACH A.: Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction. Liver Int., 29 (8): , MOHAMED A. RADY, NASHWA SHEBLE, MONA M. HASSOUNA, MONA A. EL SHAFIE, GHADA R. EL HENDAWY and DOA ZKARIA: Significance of Serum and Ascitic Fluid Bacterial DNA in Culture Negative Non-Neutrocytic Ascites. Journal of American Science, 8 (2): , 2012.

6 214 Diagnosis of Spontaneous Bacterial Peritonitis by Identification

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant

More information

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,

More information

Management of Cirrhosis Related Complications

Management of Cirrhosis Related Complications Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this

More information

Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis

Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:260 265 Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis PUNEETA TANDON*,

More information

Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis

Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis Diagnostic Value of Leucocyte Esterase Reagent Strip Test in Cirrhotic Patients with Ascites for Early Detection of Spontaneous Bacterial Peritonitis Sunil Agrawal, Barjatya H.C. Introduction The word

More information

Study of etiology, clinical profile and predictive factors of spontaneous bacterial peritonitis in cirrhosis of liver

Study of etiology, clinical profile and predictive factors of spontaneous bacterial peritonitis in cirrhosis of liver International Journal of Research in Medical Sciences Kawale JB et al. Int J Res Med Sci. 2017 Jun;5(6):2326-2330 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20172096

More information

The Use of Albumin for the Prevention of Hepatorenal Syndrome in Patients with Spontaneous Bacterial Peritonitis and Cirrhosis

The Use of Albumin for the Prevention of Hepatorenal Syndrome in Patients with Spontaneous Bacterial Peritonitis and Cirrhosis The Use of Albumin for the Prevention of Hepatorenal Syndrome in Patients with Spontaneous Bacterial Peritonitis and Cirrhosis http://www.funnyjunk.com/funny_pictures/1743659/enlarged/ Daniel Giddings,

More information

Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial

Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial Med. J. Cairo Univ., Vol. 80, No. 2, December: 71-78, 2012 www.medicaljournalofcairouniversity.com Oral Levofloxacin Versus Intravenous Cefotaxime in the Treatment of Patients with Spontaneous Bacterial

More information

Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis ABSTRACT

Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis ABSTRACT Original Article 91 Validation of Reagent Strips, Comparing with Automated and Manual Cell Counts for the Diagnosis of Spontaneous Bacterial Peritonitis Limmathurotsakul D 1 Bhokaisawan N 2 Thaimai P 1

More information

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver

More information

Infections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital

Infections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital Infections In Cirrhotic patients Dr Abid Suddle Institute of Liver Studies King s College Hospital Infection in cirrhotic patients Leading cause morbidity/mortality Common: 30-40% of hospitalised cirrhotic

More information

Ascites is the most common complication of cirrhosis and. Natural History of Patients Hospitalized for Management of Cirrhotic Ascites

Ascites is the most common complication of cirrhosis and. Natural History of Patients Hospitalized for Management of Cirrhotic Ascites CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:1385 1394 Natural History of Patients Hospitalized for Management of Cirrhotic Ascites RAMON PLANAS,* SILVIA MONTOLIU,* BELEN BALLESTÉ, MONICA RIVERA, MIREIA

More information

JMSCR Vol 05 Issue 04 Page April 2017

JMSCR Vol 05 Issue 04 Page April 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i4.202 A Study on Clinical and Laboratory Features

More information

Corresponding Author: Dr. Ali Saqib, Department of Medicine, Madina Teaching Hospital, Faisalabad.

Corresponding Author: Dr. Ali Saqib, Department of Medicine, Madina Teaching Hospital, Faisalabad. Original Article FREQUENCY OF SPONTANEOUS BACTERIAL PERITONITIS (SBP) IN CIRRHOTIC PATIENTS WITH ASCITES DUE TO HEPATITIS B AND C Ali Saqib 1, Rizwan Rasul Khan 2, Zahid Masood 3, Irshad ul Haque 4 1 Assistant

More information

Life Science Journal 2015;12(12)

Life Science Journal 2015;12(12) Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis Hassan Hamdy 1 ; Ahmed ElBaz 1 ; Ramadan Essa 1 ; Dina Soliman 2 1 Department of Tropical Medicine, Gastroenterology and Hepatology,

More information

EVALUATION OF MODEL FOR END STAGE LIVER DISEASE (MELD) SCORE IN SPONTANEOUS BACTERIAL PERITONITIS (SBP) IN PATIENTS WITH LIVER CIRRHOSIS

EVALUATION OF MODEL FOR END STAGE LIVER DISEASE (MELD) SCORE IN SPONTANEOUS BACTERIAL PERITONITIS (SBP) IN PATIENTS WITH LIVER CIRRHOSIS ANJUM ET AL (2016), FUUAST J. BIOL., 6(1): 25-32 EVALUATION OF MODEL FOR END STAGE LIVER DISEASE () SCORE IN SPONTANEOUS BACTERIAL PERITONITIS (SBP) IN PATIENTS WITH LIVER CIRRHOSIS HAFIZ SOHAIL ANJUM

More information

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS

INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS INCIDENCE OF BACTERIAL INFECTIONS IN CIRRHOSIS Yoshida H et al (1993)* Deschenes M et al (1999)** Strauss E et al (1993) Borzio M et al (2002) PATIENTS 1140 140 170 405 INFECTIONS 15.4% 20% 47% 34% * Many

More information

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments

More information

Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis

Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis POSter PreSentAtIOn Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis Fatih Ensaroğlu, 1 Murat Korkmaz, 1 Ali Ümit Geçkil, 2 Serkan

More information

Cirrhosis Complications

Cirrhosis Complications Cirrhosis Complications and Spontaneous Bacterial Peritonitis While these complications greatly increase mortality from decompensated cirrhosis, effective treatment is possible with early diagnosis. Vigilant

More information

Hyaluronic Acid (HA) Level in Ascitic Fluid of Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP)

Hyaluronic Acid (HA) Level in Ascitic Fluid of Cirrhotic Patients with Spontaneous Bacterial Peritonitis (SBP) Med. J. Cairo Univ., Vol. 81, No. 1, December: 89-813, 213 www.medicaljournalofcairouniversity.net Hyaluronic Acid (HA) Level in Ascitic Fluid of Cirrhotic Patients with Spontaneous Bacterial Peritonitis

More information

ASCITES. Dr KS Cheung Queen Mary Hospital

ASCITES. Dr KS Cheung Queen Mary Hospital ASCITES Dr KS Cheung Queen Mary Hospital Outline Pathophysiology Differential diagnosis of ascites Diagnostic paracentesis Ascitic fluid analysis Management of Ascites Management of spontaneous bacterial

More information

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015 ESLD a Guide for HIV Physicians Marion Peters University of California San Francisco June 2015 Disclosures Honararia from Johnson and Johnson Roche Merck Gilead Spouse employee of Hoffman La Roche Natural

More information

Improving the management of spontaneous bacterial peritonitis in cirrhotic patients: assessment of an intervention in trainee doctors

Improving the management of spontaneous bacterial peritonitis in cirrhotic patients: assessment of an intervention in trainee doctors ORIGINAL RESEARCH Clinical Medicine 2015 Vol 15, No 5: 426 30 Improving the management of spontaneous bacterial peritonitis in cirrhotic patients: assessment of an intervention in trainee doctors Authors:

More information

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS

More information

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Slide 1 of 32 End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California

More information

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,

More information

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES YEON SEOK SEO, 1 SOO YOUNG PARK, 2 MOON YOUNG KIM, 3 SANG GYUNE KIM, 4 JUN YONG PARK, 5 HYUNG JOON YIM,

More information

Adrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone ABSTRACT

Adrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone ABSTRACT 20 Original Article Adrenal Insufficiency in Patients with Liver Cirrhosis and Severe Sepsis: Effect on Survival after Treatment with Hydrocortisone Pattanasirigool C Prasongsuksan C Settasin S Letrochawalit

More information

TREBALL DE RECERCA. Facultat de Medicina Departament de Medicina Hospital de la Santa Creu i Sant Pau

TREBALL DE RECERCA. Facultat de Medicina Departament de Medicina Hospital de la Santa Creu i Sant Pau TREBALL DE RECERCA INSUFICIÈNCIA RENAL I MORTALITAT DELS PACIENTS CIRRÒTICS AMB PERITONITIS BACTERIANA ESPOTÀNIA I BAIX RISC DE MORTALITAT NO TRACTATS AMB ALBÚMINA. Facultat de Medicina Departament de

More information

Care of the Patient With Cirrhosis

Care of the Patient With Cirrhosis REVIEW Care of the Patient With Cirrhosis Anitha Yadav, M.D., and Hugo E. Vargas, M.D. Caring for patients with cirrhosis involves multidisciplinary and timely management of several complications while

More information

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals. Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship

More information

CIRRHOSIS Definition

CIRRHOSIS Definition Cirrhosis Update Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology Weill Cornell Medical College CIRRHOSIS Definition Irreversible fibrous

More information

Pleural fluid. creatinine - urinothorax haematocrit -haemothorax bilirubin gut perforation. Fluid samples 1st Plain Universal ( cell count)

Pleural fluid. creatinine - urinothorax haematocrit -haemothorax bilirubin gut perforation. Fluid samples 1st Plain Universal ( cell count) Examination Purpose of test Sample 17725 Fluid Profile (appearance, culture, WBC differential, ph, total protein, glucose, amylase, triglyceride, albumin, HDL) Peritoneal/ascitic and pleural fluid are

More information

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Original Article Page 1 of 9 Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis Rui Sun*, Xingshun Qi* #, Deli Zou, Xiaodong Shao, Hongyu Li, Xiaozhong

More information

Denver Shunts vs TIPS for Ascites

Denver Shunts vs TIPS for Ascites Denver Shunts vs TIPS for Ascites Hooman Yarmohammadi MD Assistant Professor of Radiology Interventional Radiology & Image Guided Therapies Memorial Sloan-Kettering Cancer Center, New York, USA Hooman

More information

Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial Peritonitis

Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial Peritonitis ISPUB.COM The Internet Journal of Gastroenterology Volume 6 Number 1 Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial

More information

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

following the last documented transfusion; thereafter, evaluate the residual impairment(s). Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood

More information

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,

More information

PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS IN CIRRHOSIS

PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS IN CIRRHOSIS PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS IN CIRRHOSIS Dr. J. Fernández. Head of the Liver Unit Hospital Clinic Barcelona, Spain AEEH Postgraduate Course, Madrid, February 15 2017 Prevalence of

More information

Causes of Liver Disease in US

Causes of Liver Disease in US Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,

More information

Cirrhosis is an important cause of morbidity and mortality

Cirrhosis is an important cause of morbidity and mortality CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:487 493 Role of Fluoroquinolones in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis: Meta-Analysis ROHIT LOOMBA,* ROBERT WESLEY, ANDREW BAIN,*

More information

Detection and significance of PD-1.3 SNP (rs ) and IL28B SNP (rs ) in patients with current or past hepatitis B virus (HBV) infection

Detection and significance of PD-1.3 SNP (rs ) and IL28B SNP (rs ) in patients with current or past hepatitis B virus (HBV) infection Detection and significance of PD-1.3 SNP (rs11568821) and IL28B SNP (rs12979860) in patients with current or past hepatitis B virus (HBV) infection Asterios Saitis 1, Nikolaos K. Gatselis 1, Kalliopi Azariadi

More information

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure

More information

Role of Rifaximin and Zinc in Secondary Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients

Role of Rifaximin and Zinc in Secondary Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients World Journal of Medical Sciences 13 (4): 255-261, 2016 ISSN 1817-3055 IDOSI Publications, 2016 DOI: 10.5829/idosi.wjms.2016.255.261 Role of Rifaximin and Zinc in Secondary Prevention of Spontaneous Bacterial

More information

Study of bacteriological profile in spontaneous bacterial peritonitis in cirrhotic patients at a tertiary teaching hospital in Northern India

Study of bacteriological profile in spontaneous bacterial peritonitis in cirrhotic patients at a tertiary teaching hospital in Northern India INTERNATIONAL JOURNAL OF CURRENT RESEARCH IN BIOLOGY AND MEDICINE ISSN: 2455-944X www.darshanpublishers.com DOI:10.22192/ijcrbm Volume 3, Issue 3-2018 Original Research Article Study of bacteriological

More information

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality

More information

Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?

Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis? Cirrhosis with : Is the presence of hemorrhagic an indicator of poor prognosis? LIVER Hakan Yıldız, Meral Akdoğan, Nuretdin Suna, Erkin Öztaş, Ufuk B. Kuzu, Zülfükar Bilge, Onur Aydınlı, İsmail Taşkıran

More information

Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis

Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis ORIGINAL ARTICLE In-hospital mortality in patients with spontaneous bacterial peritonitis., 2012; 11 (6): 915-920 November-December, Vol. 11 No.6, 2012: 915-920 915 Prognostic factors associated with in-hospital

More information

ORIGINAL PAPERS. Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study

ORIGINAL PAPERS. Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study ORIGINAL PAPERS Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study Luigi Melcarne 1, Julia Sopeña 3, Francisco José Martínez-Cerezo

More information

Value of Different Diagnostic Markers in Spontaneous Bacterial Peritonitis in HCV Egyptian Cirrhotic Patients

Value of Different Diagnostic Markers in Spontaneous Bacterial Peritonitis in HCV Egyptian Cirrhotic Patients Open Journal of Gastroenterology, 2015, 5, 119-128 Published Online September 2015 in SciRes. http://www.scirp.org/journal/ojgas http://dx.doi.org/10.4236/ojgas.2015.59020 Value of Different Diagnostic

More information

Hepatorenal syndrome. Jan T. Kielstein Departent of Nephrology Medical School Hannover

Hepatorenal syndrome. Jan T. Kielstein Departent of Nephrology Medical School Hannover Hepatorenal syndrome Jan T. Kielstein Departent of Nephrology Medical School Hannover Hepatorenal Syndrome 1) History of HRS 2) Pathophysiology of HRS 3) Definition of HRS 4) Clinical presentation of HRS

More information

Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis

Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis 168 Original Article Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis Ramin Behroozian 1*, Mehrdad Bayazidchi 1, Javad Rasooli 1 1. Department

More information

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:

More information

Managing Cirrhosis. Cirrhosis of the liver is a progressive, fibrosing. Ascites. By Cameron Ghent, MD, FRCPC. Complications of Cirrhosis

Managing Cirrhosis. Cirrhosis of the liver is a progressive, fibrosing. Ascites. By Cameron Ghent, MD, FRCPC. Complications of Cirrhosis Focus on CME at the University of Western Ontario Managing Cirrhosis By Cameron Ghent, MD, FRCPC Cirrhosis of the liver is a progressive, fibrosing process resulting in nodule formation and microvascular

More information

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P.

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P. IOSR Journal of Dental and Medical Sciences (IOSRJDMS) eissn: 227903, pissn: 2279061.Volume 16, Issue 12 Ver. III (Dec. 2017), PP 0107 www.iosrjournals.org Comparative Utility of SAAG (Sero Ascitic Albumin

More information

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications

More information

February 1, 2016 Body Fluid order changes

February 1, 2016 Body Fluid order changes February 1, 2016 Body order changes Laboratory will be making the following changes to Body tests: 1. Changing orders in Power plans (see below list). 2. All folders will be updated accordingly: If the

More information

Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis

Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis ORIGINAL ARTICLE 2018 Mar 6. [Epub ahead of print] Clinical impact of healthcare-associated acquisition in cirrhotic patients with community-onset spontaneous bacterial peritonitis Jungok Kim 1, Cheol-In

More information

Procalcitonin as a Marker of Infection in Patients with Liver Cirrhosis Compared to C-Reactive Protein

Procalcitonin as a Marker of Infection in Patients with Liver Cirrhosis Compared to C-Reactive Protein Med. J. Cairo Univ., Vol. 84, No. 2, September: 163-167, 2016 www.medicaljournalofcairouniversity.net Procalcitonin as a Marker of Infection in Patients with Liver Cirrhosis Compared to C-Reactive Protein

More information

Title: Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study

Title: Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study Title: Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study Authors: Luigi Melcarne, Julia Sopeña, Francisco José Martínez-Cerezo,

More information

Stick or twist management options in hepatitis C

Stick or twist management options in hepatitis C Stick or twist management options in hepatitis C Dr. Chris Durojaiye & Dr. Matthijs Backx SpR Microbiology and Infectious Diseases University Hospital of Wales, Cardiff Patient history 63 year old female

More information

Anaesthetic considerations and peri-operative risks in patients with liver disease

Anaesthetic considerations and peri-operative risks in patients with liver disease Anaesthetic considerations and peri-operative risks in patients with liver disease Dr. C. K. Pandey Professor & Head Department of Anaesthesiology & Critical Care Medicine Institute of Liver and Biliary

More information

Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis

Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis Iran J Public Health, Vol. 47, No.12, Dec 2018, pp.1883-1890 Original Article Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis Yuan WANG, *Qingyu

More information

BETA-BLOCKERS IN CIRRHOSIS.PRO.

BETA-BLOCKERS IN CIRRHOSIS.PRO. BETA-BLOCKERS IN CIRRHOSIS.PRO. Angela Puente Sánchez. MD PhD Hepatology Unit. Gastroenterology department Marques de Valdecilla University Hospital. Santander INTRODUCTION. Natural history of cirrhosis

More information

The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis

The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;

More information

ORIGINAL ARTICLE. Jun Zheng 1, Rong-chun Xing 1, Wei-hong Zheng 2, Wei Liu 1, Ru-cheng Yao 1, Xiao-song Li 1, Jian-ping Du 1, Lin Li 1.

ORIGINAL ARTICLE. Jun Zheng 1, Rong-chun Xing 1, Wei-hong Zheng 2, Wei Liu 1, Ru-cheng Yao 1, Xiao-song Li 1, Jian-ping Du 1, Lin Li 1. JBUON 2017; 22(3): 709-713 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A comparative study on postoperative mortality prediction of SFLI scoring

More information

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number: Cirrhosis Care Bundle CONTROLLED DOCUMENT CATEGORY: Clinical Guidelines CLASSIFICATION: Clinical Controlled Document CG201 Number: Version Number: 1 Controlled Document Clinical Guidelines Group Sponsor:

More information

JMSCR Vol 05 Issue 11 Page November 2017

JMSCR Vol 05 Issue 11 Page November 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i11.33 Prevalence of Hyponatremia among patients

More information

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology

More information

Ascites. Matthew Johnson M.D.

Ascites. Matthew Johnson M.D. Ascites Matthew Johnson M.D. The most common complication of portal hypertension 50% of patients who have compensated cirrhosis develop ascites by 10 years Survival after ascites develops: 1-year: 85%

More information

Fecal Calprotectin in Patients with Hepatic Encephalopathy

Fecal Calprotectin in Patients with Hepatic Encephalopathy 62 Fecal Calprotectin in Patients with Hepatic Encephalopathy Amany Lashin 1, Tamer E. El-Eraky 1, Waleed El-Eraky Al Azab 2, Amira Nour Eldin 3 and Ahmed Abd Almaksoud Amer 4 1 Hepatology, Gastroenterology

More information

The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases

The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases RESEARCH ARTICLE The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases Objective: This study aimed to investigate the value of liver fibrosis assessment

More information

Abdominal Paracentesis: Safety and Efficacy Comparing Medicine Resident Bedside Paracentesis vs. Paracentesis Performed by Interventional Radiology

Abdominal Paracentesis: Safety and Efficacy Comparing Medicine Resident Bedside Paracentesis vs. Paracentesis Performed by Interventional Radiology Research Article imedpub Journals www.imedpub.com DOI: 10.21767/2575-7733.1000050 Journal of Clinical Gastroenterology and Hepatology Abdominal Paracentesis: Safety and Efficacy Comparing Medicine Resident

More information

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols

More information

Medicine. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension

Medicine. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension Medicine OBSERVATIONAL STUDY Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension Hitoshi Maruyama, MD, PhD, Takayuki Kondo, MD, PhD, Tadashi Sekimoto, MD, PhD, and Osamu

More information

A Case of Pneumatosis Cystoides Intestinalis Mimicking Intestinal Perforation

A Case of Pneumatosis Cystoides Intestinalis Mimicking Intestinal Perforation Showa Univ J Med Sci 26 2, 169 173, June 2014 Case Report A Case of Pneumatosis Cystoides Intestinalis Mimicking Intestinal Perforation Takahiro UMEMOTO 1, Yoshikuni HARADA 1, Makiko SAKATA 1, Gaku KIGAWA

More information

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed? The Hospitalist. 2016 August;2016(8) Author(s): Raj Sehgal, MD; Joshua Hanson, MD, MPH; Division OF The

More information

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis Diagnostic Problems in Hepatology 181 Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis Carmen Sendra, MD 1 Javier Ampuero, MD, PhD 1,2 Álvaro

More information

GI bleeding in chronic liver disease

GI bleeding in chronic liver disease GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old

More information

The Importance of Diagnosing Covert Hepatic Encephalopathy

The Importance of Diagnosing Covert Hepatic Encephalopathy The Importance of Diagnosing Covert Hepatic Encephalopathy Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council

More information

Prof. Mohammad Umar. MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA

Prof. Mohammad Umar. MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA Prof. Mohammad Umar MBBS, MCPS, FCPS, FACG (USA), FRCP (London), FRCP (Glasgow), FAGA Chairman and Head Department of Medicine Rawalpindi Medical College, Rawalpindi. Consultant Gastroenterologist / Hepatologist

More information

King Abdul-Aziz University Hospital (KAUH) is a tertiary

King Abdul-Aziz University Hospital (KAUH) is a tertiary Modelling Factors Causing Mortality in Oesophageal Varices Patients in King Abdul Aziz University Hospital Sami Bahlas Abstract Objectives: The objective of this study is to reach a model defining factors

More information

Treatment of chronic hepatitis delta Case report

Treatment of chronic hepatitis delta Case report Treatment of chronic hepatitis delta Case report George Papatheodoridis Professor in Medicine & Gastroenterology Medical School of National and Kapodistrian University of Athens, Director of Academic Department

More information

Ascites and Related Disorders. Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016

Ascites and Related Disorders. Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016 Ascites and Related Disorders Luis S. Marsano, MD Professor of Medicine Director of Hepatology University of Louisville 2016 Causes of Ascites Malignant Neoplasia 10% Cardiac Insufficiency 3% Chronic hepatic

More information

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal

More information

Renalase: A Novel Inflamatory Marker Post Living Donor Liver Transplantation

Renalase: A Novel Inflamatory Marker Post Living Donor Liver Transplantation Med. J. Cairo Univ., Vol. 86, No. 5, September: 2741-2745, 2018 www.medicaljournalofcairouniversity.net Renalase: A Novel Inflamatory Marker Post Living Donor Liver Transplantation AHMED M. ABDUL GHANI,

More information

The high prevalence of Listeria monocytogenes peritonitis in cirrhotic patients of an Egyptian Medical Center

The high prevalence of Listeria monocytogenes peritonitis in cirrhotic patients of an Egyptian Medical Center Journal of Infection and Public Health (2011) 4, 211 216 SHORT REPORT The high prevalence of Listeria monocytogenes peritonitis in cirrhotic patients of an Egyptian Medical Center Maysaa El Sayed Zaki

More information

CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS

CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Pere Ginès, MD Liver Unit, Hospital Clínic Barcelona, Catalunya, Spain CIRCULATORY AND RENAL FAILURE IN CIRRHOSIS Hecker R and Sherlock S, The Lancet 1956 RENAL

More information

SOFA Score as a Predictor of Mortality in Critically Ill Cirrhotic Patients. Critical Care Department, Theodor Bilharz Research Institute (TBRI) (2)

SOFA Score as a Predictor of Mortality in Critically Ill Cirrhotic Patients. Critical Care Department, Theodor Bilharz Research Institute (TBRI) (2) SOFA Score as a Predictor of Mortality in Critically Ill Cirrhotic Patients Ahmed Alsherif (1), Hisham Darwesh (1), Mohamed Badr (1), Mervat Eldamarawy (1), Ahmed Shawky (2) and Azza Emam (2) (1) Critical

More information

Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors

Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Fred Poordad, MD The Texas Liver Institute Clinical Professor of Medicine University of Texas Health Science Center

More information

T here is an increasing discrepancy between the number of

T here is an increasing discrepancy between the number of 134 LIVER DISEASE MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study F Botta, E Giannini, P Romagnoli,

More information

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients Gut and Liver, Vol. 10, No. 1, January 2016, pp. 95-100 ORiginal Article Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in and Cirrhosis Patients Hee Yeon Kim, Chang

More information

The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality

The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality Sammy Saab, 1,2 Carmen Landaverde, 3 Ayman B Ibrahim, 2 Francisco Durazo, 1,2 Steven Han, 1,2 Hasan

More information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob: Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).

More information

Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis

Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis The Turkish Journal of Pediatrics 2015; 57: 492-497 Original Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis Aysel Ünlüsoy-Aksu 1,

More information

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,

More information

Update in abdominal Surgery in cirrhotic patients

Update in abdominal Surgery in cirrhotic patients Update in abdominal Surgery in cirrhotic patients Safi Dokmak HBP department and liver transplantation Beaujon Hospital, Clichy, France Cairo, 5 April 2016 Cirrhosis Prevalence in France (1%)* Patients

More information

Long term administration of human albumin improves survival in patients with cirrhosis and refractory ascites

Long term administration of human albumin improves survival in patients with cirrhosis and refractory ascites Received: 3 May 2018 Revised: 2 August 2018 Accepted: 12 September 2018 DOI: 10.1111/liv.13968 CIRRHOSIS AND LIVER FAILURE Long term administration of human albumin improves survival in patients with cirrhosis

More information